Frazier Lifesciences Acquisition Corporation Unit

10.26+0.0500+0.49%Vol 3.90K1Y Perf 0.29%
Apr 9th, 2021 15:59 DELAYED
BID10.21 ASK10.36
Open10.22 Previous Close10.21
Pre-Market- After-Market-
 - -  - -%
Target Price
- 
Analyst Rating
— — 0.00
Potential %
- 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12 mo.
-/-/- 
Value Ranking
 —    -
Insiders Value % 3/6/12 mo.
-/-/- 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12 mo.
-/-/- 
Income Ranking
 —    -
Market Cap- 
Earnings Rating
Price Range Ratio 52W %
38.00 
Earnings Date
-

Today's Price Range

10.2110.31

52W Range

9.5011.50

Summary:

Neutral

Technical Indicators: Neutral
Moving Averages: Neutral
Performance
1 Week
1.28%
1 Month
-1.35%
3 Months
-4.11%
6 Months
-
1 Year
0.29%
3 Years
-
5 Years
-
10 Years
-

TickerPriceChg.Chg.%
FLACU10.260.05000.49
AAPL132.992.63002.02
GOOG2 285.8820.44000.90
MSFT255.852.60001.03
XOM55.87-0.1300-0.23
WFC40.500.47001.17
JNJ161.25-1.7200-1.06
FB312.46-0.5600-0.18
GE13.600.15001.12
JPM156.281.16000.75
Earnings HistoryEstimateReportedSurprise %
----
----
----
----
----
----
----
----
Earnings Per EndEstimateRevision %Trend
----
----
----
----
Next Report Date-
Estimated EPS Next Report-
Estimates Count-
EPS Growth Next 5 Years %-
Volume Overview
Volume3.90K
Shares Outstanding0
Trades Count25
Dollar Volume757.25K
Avg. Volume37.27K
Avg. Weekly Volume4.68K
Avg. Monthly Volume12.73K
Avg. Quarterly Volume37.80K

Frazier Lifesciences Acquisition Corporation Unit (NASDAQ: FLACU) stock closed at 10.26 per share at the end of the most recent trading day (a 0.49% change compared to the prior day closing price) with a volume of 3.90K shares and market capitalization of 0.0000. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Diversified Financial Services industry, Financial Services sector and employs 4 people. Frazier Lifesciences Acquisition Corporation Unit CEO is James N. Topper.

The one-year performance of Frazier Lifesciences Acquisition Corporation Unit stock is 0.29%, while year-to-date (YTD) performance is -1.16%. FLACU stock has a five-year performance of %. Its 52-week range is between 9.5 and 11.5, which gives FLACU stock a 52-week price range ratio of 38.00%

Frazier Lifesciences Acquisition Corporation Unit currently has a PE ratio of -, a price-to-book (PB) ratio of -, a price-to-sale (PS) ratio of -, a price to cashflow ratio of -, a PEG ratio of 2.32, a ROA of -0.09%, a ROC of -0.19% and a ROE of -0.09%. The company’s profit margin is -%, its EBITDA margin is -%, and its revenue ttm is $0.00 , which makes it $0.00 revenue per share.

Of the last four earnings reports from Frazier Lifesciences Acquisition Corporation Unit, there were 0 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $0.00 for the next earnings report. Frazier Lifesciences Acquisition Corporation Unit’s next earnings report date is -.

The consensus rating of Wall Street analysts for Frazier Lifesciences Acquisition Corporation Unit is (), with a target price of $, which is 0.00% compared to the current price. The earnings rating for Frazier Lifesciences Acquisition Corporation Unit stock is (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Frazier Lifesciences Acquisition Corporation Unit has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Frazier Lifesciences Acquisition Corporation Unit has a Neutral technical analysis rating based on Technical Indicators (ADX : 16.81, ATR14 : 0.18, CCI20 : -129.96, Chaikin Money Flow : 0.10, MACD : 0.01, Money Flow Index : 23.81, ROC : -8.77, RSI : 43.41, STOCH (14,3) : 6.25, UO : 27.90, Williams %R : -93.75), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Frazier Lifesciences Acquisition Corporation Unit in the last 12-months were:

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
0
0
0
Moderate Buy
0
0
0
Hold
0
0
0
Moderate Sell
0
0
0
Strong Sell
0
0
0
Summary Rating---

Frazier Lifesciences Acquisition Corporation Unit

Frazier Lifesciences Acquisition Corp is a blank check company.

CEO: James N. Topper

Telephone: +1 206 621-7200

Address: 601 Union Street, Seattle 98101, WA, US

Number of employees: 4

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

100%0%

Bearish Bullish

100%0%

Bearish Bullish

100%0%

Bearish Bullish

100%0%

News

Stocktwits